Zozaya, N., Abdalla, F., Alfonso Zamora, S., Balea Filgueiras, J., Carrascosa, J. M., Delgado Sánchez, O., . . . Hidalgo, Á. (2022). Assessing the value contribution of bimekizumab for the treatment of moderate-to-severe psoriasis using a multidisciplinary reflective multi-criteria decision analysis.
Citación estilo ChicagoZozaya, Néboa|||0000-0003-4618-6894, et al. Assessing the Value Contribution of Bimekizumab for the Treatment of Moderate-to-severe Psoriasis Using a Multidisciplinary Reflective Multi-criteria Decision Analysis. 2022.
Cita MLAZozaya, Néboa|||0000-0003-4618-6894, et al. Assessing the Value Contribution of Bimekizumab for the Treatment of Moderate-to-severe Psoriasis Using a Multidisciplinary Reflective Multi-criteria Decision Analysis. 2022.